Paxman AB (publ) (STO:PAX)

Market Cap	1.60B
Revenue (ttm)	272.09M
Net Income (ttm)	21.58M
Shares Out	20.91M
EPS (ttm)	1.12
PE Ratio	68.21
Forward PE	27.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,205
Average Volume	72,978
Open	78.80
Previous Close	76.60
Day's Range	77.00 - 81.60
52-Week Range	45.50 - 85.80
Beta	0.36
RSI	58.92
Earnings Date	Aug 20, 2025

About Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to utilize state-of-the-art technological advances to develop a wearable medical cooling device, and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 105
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PAX

Financial Performance

In 2024, Paxman AB's revenue was 263.20 million, an increase of 19.30% compared to the previous year's 220.61 million. Earnings were 40.20 million, an increase of 382.55%.